Quality & Compliance
FDA 503B Registered Facility
Apertus Compounding operates as a 503B Outsourcing Facility, adhering to Current Good Manufacturing Practices (cGMP) as defined by the FDA.
Sterility Assurance
Every batch undergoes rigorous sterility and endotoxin testing before release.
Environmental Monitoring
Continuous monitoring of our ISO-classified cleanrooms ensures constant compliance.